Abstract:The polyamines putrescine, spermidine, and spermine are widely distributed polycationic compounds essential for cellular functions. Intracellular polyamine pools are tightly regulated by a complex regulatory mechanism involving de novo biosynthesis, catabolism, and transport across the plasma membrane. In mammals, both the production of polyamines and their uptake from the extracellular space are controlled by a set of proteins named antizymes and antizyme inhibitors. Dysregulation of polyamine levels has been implicated in a variety of human pathologies, especially cancer. Additionally, decreases in the intracellular and circulating polyamine levels during aging have been reported. The differences in the polyamine content existing among tissues are mainly due to the endogenous polyamine metabolism. In addition, a part of the tissue polyamines has its origin in the diet or their production by the intestinal microbiome. Emerging evidence has suggested that exogenous polyamines (either orally administrated or synthetized by the gut microbiota) are able to induce longevity in mice, and that spermidine supplementation exerts cardioprotective effects in animal models. Furthermore, the administration of either spermidine or spermine has been shown to be effective for improving glucose homeostasis and insulin sensitivity and reducing adiposity and hepatic fat accumulation in diet-induced obesity mouse models. The exogenous addition of agmatine, a cationic molecule produced through arginine decarboxylation by bacteria and plants, also exerts significant effects on glucose metabolism in obese models, as well as cardioprotective effects. In this review, we will discuss some aspects of polyamine metabolism and transport, how diet can affect circulating and local polyamine levels, and how the modulation of either polyamine intake or polyamine production by gut microbiota can be used for potential therapeutic purposes.

Research advances in the role of polyamine metabolism in aging and heart failure

Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases

Dynamic Mitochondrial Proteome Under Polyamines Treatment in Cardiac Aging

Spermine and spermidine reversed age-related cardiac deterioration in rats.

The Molecular Role of Polyamines in Age-Related Diseases: An Update

Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function

New Insights into the Roles and Mechanisms of Spermidine in Aging and Age-Related Diseases

Potential regulatory role of epigenetic modifications in aging-related heart failure

Polyamines in Ovarian Aging and Disease

Special Issue "Polyamines in Aging and Disease"

Cardiac Aging: From Basic Research to Therapeutics

Gut microbiota and anti-aging: Focusing on spermidine

Spermidine Inhibits Neurodegeneration and Delays Aging Via the PINK1-PDR1-dependent Mitophagy Pathway in C. Elegans.

Advances in Research on Effects of Polyamines on Fruit Growth and Development of Fruit Trees

Recent Advances in Natriuretic Peptide Family Genes and Cardiovas-Cular Diseases

Age-associated polyamines in peripheral blood cells and plasma in 20 to 70 years of age subjects

Cardioprotection and lifespan extension by the natural polyamine spermidine

Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection

Polyamines and Their Metabolism: From the Maintenance of Physiological Homeostasis to the Mediation of Disease

Polyamines: their significance for maintaining health and contributing to diseases

Decrease in polyamines with aging and their ingestion from food and drink